These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25715973)

  • 1. Lung cancer CT screening is cost-effective but implementation matters.
    Goulart B
    Evid Based Med; 2015 Apr; 20(2):78. PubMed ID: 25715973
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Tierney WM
    N Engl J Med; 2015 Jan; 372(4):387-8. PubMed ID: 25607439
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Pinsky PF
    N Engl J Med; 2015 Jan; 372(4):387. PubMed ID: 25607438
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Keeler EB; Soneji SS
    N Engl J Med; 2015 Jan; 372(4):388. PubMed ID: 25607437
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care perspective on lung cancer screening.
    Leventhal W
    J Thorac Imaging; 2012 Jul; 27(4):209-10. PubMed ID: 22847587
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness of chest CT in T1N0M0 lung cancer.
    Black WC; Armstrong P; Daniel TM
    Radiology; 1988 May; 167(2):373-8. PubMed ID: 3128840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for lung cancer using CT: time for implementation?].
    de Jong PA; Lammers JW
    Ned Tijdschr Geneeskd; 2013; 157(46):A7019. PubMed ID: 24220184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.
    Tomonaga Y; Ten Haaf K; Frauenfelder T; Kohler M; Kouyos RD; Shilaih M; Lorez M; de Koning HJ; Schwenkglenks M; Puhan MA
    Lung Cancer; 2018 Jul; 121():61-69. PubMed ID: 29858029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
    Puggina A; Broumas A; Ricciardi W; Boccia S
    Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic impact of lung cancer screening in France: A modeling study].
    Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
    Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
    Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
    Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT screening for lung cancer shown to be cost-effective.
    Granovetter M
    Lancet Respir Med; 2014 Dec; 2(12):973. PubMed ID: 25621345
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term Oncologic and financial implications of lung cancer screening.
    Pedersen JH; Sørensen JB
    Thorac Surg Clin; 2015 May; 25(2):223-9. PubMed ID: 25901566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening with low-dose CT (LDCT), or when a public health intervention is beyond the patient's benefit.
    Ruano-Ravina A; Heleno B; Fernández-Villar A
    J Epidemiol Community Health; 2015 Feb; 69(2):99-100. PubMed ID: 25138391
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.